Free Flow Medical, Inc.

FREMONT, CA · Founded 2017 · Medtech · Private

FreeFlow Coil System, a minimally invasive intrabronchial implant device for severe emphysema treatment

Claim this profile

Follows are private to you and power your alerts

Updated · freeflowmedical.com

Sector
Medtech
Headquarters
FREMONT, CA
Founded
2017
Latest Form D
$5.1M, Apr 2023
Total capital
$10.1M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$10.1M
3 Form D · last Apr 2023
43 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
16 pending · first 2020
Rank in peer group#286 of 1112

Capital timeline

20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $10.1M1st Form D$2.8M2nd Form D$2.1M3rd Form D$5.1M
20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $10.1M2nd Form D$2.1M3rd Form D$5.1M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$5.1M
  • Private capital raisedForm D · SEC · 2nd filing$2.1M
  • Private capital raisedForm D · SEC · 1st filing$2.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#286 · top 26%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Mark MathisResearcherExecutive Officer, DirectorLinked by 6 patents
  • David PaulDirectorNamed in SEC Form D filings
  • Kim MathisExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 22
Show all 22 patent records
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilJun 23, 2026 · US 12,661,123Granted
  • Devices, Methods, And Systems To Treat Chronic BronchitisMay 12, 2026 · US 12,622,724Granted
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApr 23, 2026 · Application 19355928Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilFeb 24, 2026 · US 12,558,099Granted
  • Devices, Methods, And Systems To Treat Chronic BronchitisSep 30, 2025 · US 12,426,916Granted
  • Devices, Methods, And Systems To Treat Chronic BronchitisSep 23, 2025 · US 12,419,664Granted
  • Valved Devices, Treatments And Methods To Restore Tissue Elastic RecoilNov 21, 2024 · Application 18286905Pending
  • Devices, Methods, And Systems To Treat Chronic BronchitisAug 29, 2024 · Application 18649422Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilJun 24, 2021 · Application 17249473Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilSep 29, 2020 · US 10,786,257Granted
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilOct 31, 2019 · Application 16444849Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication 62609761Pending
  • Valved Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication PCTUS2022025070Pending
  • Valved Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication 63175917Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication PCTUS2020063755Pending
  • Devices, Methods, And Systems To Treat Chronic BronchitisApplication PCTUS2020050660Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication 62945510Pending
  • Devices, Methods, And Systems To Treat Chronic BronchitisApplication 62899200Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication PCTUS2018067160Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication 62749005Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication 62720004Pending
  • Devices, Treatments And Methods To Restore Tissue Elastic RecoilApplication 62651573Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .